QIAGEN,Biotype Diagnostics Form Partnership
News Jun 29, 2015
QIAGEN and Biotype Diagnostics GmbH today announced that they have entered into a partnership to establish Biotype Innovation GmbH ("Biotype Innovation").
The new company will develop and commercialize molecular diagnostic workflows initially for personalized healthcare applications based on QIAGEN’s proprietary ModaPlex platform, which enables customers to detect, characterize and measure up to 100 parameters simultaneously in a cost-effective and rapid manner.
The diagnostic assays developed by the Biotype Innovation are expected to add to the assay menu of the ModaPlex platform especially in the market for companion diagnostics, which are used to guide drug treatments.
“We are very pleased to join forces with Biotype. This partnership enables us to expand the menu of our unique ModaPlex platform, offer assay development services for pharma companies and thereby expand our leadership in companion diagnostics,” said Peer Schatz, CEO of QIAGEN. “As a long-standing partner with an unparalleled expertise in molecular analysis, Biotype is the natural partner for us.”
QIAGEN will contribute technology and access to its global commercialization engine to the joint venture, while Biotype Diagnostics GmbH will contribute know-how, assay development resources, and its scientific network. QIAGEN will have worldwide distribution rights for the assays, while Biotype Diagnostics will have co-distribution rights for Germany, Austria and Switzerland.
The partnership, structured as a joint venture, will have its head office based in Hellerau, Dresden, in newly refurbished facilities on the Campus of the Biotype Diagnostics GmbH. “The proximity will allow both companies to leverage synergies and share facilities where necessary”, says Dr. Wilhelm Zörgiebel, CEO of Biotype Diagnostics.
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Hormone-Disrupting Environmental Chemicals May be Making Us FatNews
Everyday products carry environmental chemicals that may be making us fat by interfering with our hormones, according to new research. Following recommendations on how to avoid these chemicals could help minimise exposure and potentially reduce the risk of obesity and its complications.READ MORE
Algorithm Predicts Life Expectancy After Heart AttackNews
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more personalized assessments of people who are awaiting heart transplants, which in turn could enable health care providers to make better use of limited life-saving resources and potentially reduce health care costs.
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018